Christian Dior SE (CDI)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 417.80 |
|---|---|
| 52-week range | 363.80 – 611.50 |
| Return, 1 month / 3 months | +14.4% / −0.9% |
| Return, 1 year / 3 years | −25.4% / −29.2% |
| Trend | Below its 200-day average |
| RSI (14) | 52 |
| Volatility (1 year) | 30.0% |
| Worst drawdown (1 year) | -38.7% |
| Average daily value traded | 4.22M EUR |
| Dividend yield | 3.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Christian Dior SE is a French holding company based in Paris. Through its investments it is connected to the luxury goods industry, most notably holding a controlling interest in LVMH, the group behind fashion, leather goods, perfumes, cosmetics, watches, jewellery and wines and spirits. It also owns the Christian Dior Couture fashion house, whose products include ready-to-wear clothing, handbags and accessories sold through its own boutiques and to customers around the world.
On this site Christian Dior SE appears as a stock on the Euronext Paris (France), code CDI, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Christian Dior SE (CDI) trades on the Euronext Paris in France. It last closed at EUR 417.80 on 23 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 245 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 25.4% and over the last three months it fell 0.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.4% | ||
| From 52-week high | -31.2% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -0.9% | ||
| 6-month return | -5.0% | ||
| 12-month return, skipping the last month | -34.8% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.7% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 4.22M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 70 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.4% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −3.6% |
|---|---|
| 1 month | +14.4% |
| 3 months | −0.9% |
| 6 months | −5.0% |
| 1 year | −25.4% |
| 3 years | −29.2% |
| 5 years | −30.4% |
Signals
| 50-day / 200-day average | 403.89 / 446.47 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 9.04 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Dec 2026 | EUR 6.0500 |
| 28 Apr 2026 | EUR 8.2500 |
| 2 Dec 2025 | EUR 6.0500 |
| 24 Apr 2025 | EUR 7.5000 |
| 2 Dec 2024 | EUR 5.5000 |
| 23 Apr 2024 | EUR 7.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.